在急性心肌梗塞患者中,血清度与功能恶化之间的关联:分析MIMIC-IV数据库
Xiaojia Luo1, Yong Tang2, Yanzhang Shu2
1Department of Cardiology, Chengdu Second People's Hospital, No.10 Qingyunnan Street, Jinjiang District, Chengdu, Sichuan Province, 610017, China.
BMC cardiovascular disorders
|September 13, 2024
概括
高血清度与急性心肌梗塞患者的功能恶化有关. 这一发现凸显了血清度作为该人群中功能恶化的危险因素.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 密集护理医学 密集护理医学
背景情况:
- 急性心肌梗塞 (AMI) 是一个关键的心血管事件.
- 恶化功能是AMI患者的重要并发症.
- 了解影响AMI后功能因素对于患者的治疗结果至关重要.
研究的目的:
- 研究急性心肌梗塞 (AMI) 患者血清度水平与功能恶化的风险之间的关联.
- 探索血清度与AMI患者急性损伤 (AKI) 的发生率和进展之间的关系.
主要方法:
- 一项对3885名AMI患者的回顾性研究,来自密集护理IV数据库的医学信息中心.
- 血清度被分为低 (<293.2725 mmol/L) 或高 (≥293.2725 mmol/L).
- 使用后勤回归模型来评估血清度和功能结果之间的关联,包括功能恶化,新发性AKI和AKI进展,并进行亚组分析.
主要成果:
- 1,393名AMI患者经历了功能恶化.
- 高血清度与功能恶化的风险增加显著相关 (OR=1.47,95% CI: 1.22-1.78),新发的AKI (OR=1.31,95% CI: 1.01-1.69) 和AKI进展 (OR=1.26,95% CI: 1.01-1.59) 经过对混因素进行调整后.
- 亚组分析表明,高血清度是老年患者 (≥65岁),没有心脏性休克的患者和EGFR≥60mL/min/1.73m2.2的患者功能恶化的危险因素.
结论:
- 血清度升高是急性心肌梗塞患者功能恶化的独立危险因素.
- 这些发现表明,监测血清度可能对AMI患者的风险分层和功能管理很重要.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Heart Failure Drugs: Diuretics
350
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
350
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398


